Jennison Associates
SYRE icon

Jennison Associates’s Spyre Therapeutics SYRE Stock Holding History

Jennison Associates’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,044
Closed -$6.25M – 676
2019
Q1 		$6.25M Sell
31,044
-23,028
-43% -$4.8M 0.01% 457
2018
Q4 		$10.1M Sell
54,072
-7,224
-12% -$1.53M 0.01% 434
2018
Q3 		$14.7M Buy
61,296
+278
+0.5% +$64.9K 0.01% 436
2018
Q2 		$16.1M Buy
61,018
+814
+1% +$200K 0.02% 428
2018
Q1 		$14.9M Buy
60,204
+4,466
+8% +$807K 0.01% 427
2017
Q4 		$7.54M Buy
55,738
+335
+0.6% +$41K 0.01% 479
2017
Q3 		$6.57M Sell
55,403
-464
-0.8% -$43.5K 0.01% 497
2017
Q2 		$5.36M Sell
55,867
-2,314
-4% -$320K 0.01% 505
2017
Q1 		$10.8M Buy
58,181
+352
+0.6% +$49.7K 0.01% 483
2016
Q4 		$6.29M Buy
57,829
+831
+1% +$121K 0.01% 502
2016
Q3 		$9.13M Buy
56,998
+1,475
+3% +$205K 0.01% 480
2016
Q2 		$6.69M Buy
+55,523
New +$10.6M 0.01% 491

Other funds holding SYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return